Academic, industry, and FDA collaboration is key to personalized treatment manufacturing, says Aldevron’s Max Sellman at BPI this week.

Messenger RNA, or mRNA, vaccines entered the public consciousness when they were introduced during the COVID-19 pandemic, and both Pfizer-BioNTech and Moderna used the technology in developing their ...

The United States may be losing its edge in mRNA technology­­. The technology, which powered life-saving COVID-19 vaccines and is now rocketing new cancer therapeutics forward, will soon undergo a ...

Rick Bright, the former director of the Biomedical Advanced Research and Development Authority (BARDA) has warned that Department of Health and Human Services' decision to cut funding for mRNA vaccine ...

Dr. Bright is a virologist and a former head of the Biomedical Advanced Research and Development Authority. In early 2020, when the first genetic sequence of the new coronavirus was posted online, ...

Jonathan Kagan has his sights set on next year, when the Harvard scientist plans to start clinical trials on an experimental cancer treatment based on the same technology — messenger RNA — that ...

National Institutes of Health (NIH) Director Jay Bhattacharya claims the federal government recently canceled millions of dollars’ worth of mRNA research contracts because the general public does not ...

This month, the US Department of Health and Human Services announced that it was canceling 22 contracts and investments worth nearly $500 million as a part of a “coordinated wind-down” of mRNA vaccine ...

If you think last week's decision by the federal government to halt $500 million in funding for vaccine development projects that use mRNA technology will only affect COVID vaccines, think again.

Health officials during the first term said mRNA shots are safe and effective. When the Pfizer-BioNTech COVID-19 vaccine was authorized for emergency use by the Food and Drug Administration (FDA) in ...

On first glance, the data that Health and Human Services Secretary Robert F. Kennedy Jr. cited to justify canceling some $500 million in federal grants for mRNA vaccine research looked impressive. The ...

The fate of an important breakthrough in cancer immunotherapy treatment remains in the balance following an announcement earlier this week that the Department of Health and Human Services will cancel ...